Using cell-free protein synthesis, digital microfluidics ... 60% of FDA-approved drugs target membrane proteins 1 yet the ...

Nuclera, a Cambridge biotech accelerating protein expression and optimisation, has added a new membrane protein workflow to its benchtop eProtein Discovery™ system.

Beneath the surface of the tiny, see-through worm Caenorhabditis elegans, researchers have found new clues about how certain ...

Active membrane transporter, MsbA and integral membrane protein, ZMPSTE24 synthesized ... extraction and stabilization of these structurally complex proteins remains challenging due to their ...

Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain ...

A joint research team has developed a modular protein adapter technology that enables the stable attachment of various ...

Active membrane transporter, MsbA and integral membrane protein, ZMPSTE24 synthesized CAMBRIDGE ... 60% of FDA-approved drugs target membrane proteins 1 yet the extraction and stabilization of these ...

Nuclera, the biotechnology company accelerating protein expression ... drugs target membrane proteins1 yet the extraction and stabilization of these structurally complex proteins remains ...